Our Advisory Council Member is a senior Quality and Regulatory executive with more than 25 years of leadership across pharmaceutical manufacturing, sterile compounding (503A/503B), excipient production, and regulated distribution/3PL environments. This Advisory Council Member brings deep expertise in cGMP systems, global regulatory compliance, and enterprise quality transformation across multi-site US and EU operations.

Our Advisory Council Member is a remediation-tested leader with a proven track record of stabilizing high-risk regulatory environments and restoring compliance without disrupting commercial operations. His experience includes leading FDA re-inspection turnarounds (483 observations to zero findings), executing Consent Decree remediation, and achieving EU GMP, ISO 9001, and EXCiPACT certifications with no critical or major observations.

This Advisory Council Member has built and led quality organizations of up to 100+ professionals, managed budgets exceeding $3 million, and served as the primary interface with regulatory authorities including FDA, DEA, EMA, and global health agencies. His expertise spans sterile and aseptic manufacturing, quality systems governance (CAPA, deviation, change control), supplier oversight, and inspection readiness.

At WWCA this Advisory Council Member advises on regulatory risk mitigation, quality system design, operational readiness, and remediation strategy—supporting clients across diligence, turnaround, and growth-stage scaling initiatives.